Karvy has identified the best large-cap and mid-cap stocks to buy now
Rahul Sharma of Karvy, who is an expert on the pharmaceutical sector, has conducted a detailed analysis of the past quarterly results of the best pharma companies and estimated what their future earnings will be. Based on this analysis, he has identified the stocks that investors should buy, hold or sell. A short reasoning, together with the target price, of each stock recommendation is also given.
Leave a Reply